Biotechnology | FDA | Oncology
FDA approves new pancreatic cancer drug Offering new treatment
On Aug. 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for…
-
-
Diagnostics | Disease | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress | Women's Health
American Cancer Society Reports a Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined
On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
-
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
On Sept. 10, 2025, Exact Sciences announced the launch of the Cancerguard™ test, a new multi-cancer early detection…
-
AI-Based Tool Offers Exciting Advancement in Pancreatic Cancer Diagnostics
On Dec. 12, 2024, a study co-lead by researchers from the University of British Columbia, Vancouver General Hospital…
-
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, 23andMe, a leading human genetics and biopharmaceutical company, today announced the Company has received…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
-
Siteman Cancer Center received a $10.4 million grant from the NCI
On Aug. 15, 2016, Siteman Cancer Center received a $10.4 million five-year grant to Washington University researchers and…
-
NCI five-year grant extends nanoparticle research targeting pancreatic cancer
On Oct. 1, 2015, the National Cancer Institute (NCI) awarded a $2.8 million grant five-year grant to researchers…
-
OHSU launched a $25 million clinical and translational science initiative against lethal, hard-to-treat pancreatic disease
On Sept. 12, 2013, Oregon Health & Science University (OHSU) announced it had launched a clinical and translational…
-
The Pancreatic Cancer Action Network was founded
On Feb. 8, 1999, The Pancreatic Cancer Action Network was founded by Paula Kim, Terry Lierman and Pamela…
